RaySearch Laboratories AB (publ) är glada att kunna meddela att Connecticut Proton Therapy Center, Wallingford, Connecticut, USA, har lagt en order på onkologiinformationssystemet RayCare®*.
Connecticut Proton Therapy Center kommer att vara det första i sitt slag i delstaten Connecticut. Köpet är ett samarbete mellan Yale New Haven Health, Hartford HealthCare och Proton International och avser installation av RayCare och IBA:s kompakta protonbehandlingssystem Proteus®ONE.
RayCare kommer att vara Connecticut Proton Therapy Centers enda onkologiinformationssystem och kommer att användas tillsammans med protonbehandlingssystemet ProteusONE. Centret kommer att använda RayCares arbetsflödesmotor för att utforma klinikspecifika arbetsflöden och målet är att ta RayCare i kliniskt bruk 2026, när centret öppnar. RayCare kommer att användas tillsammans med RaySearchs dosplaneringssystem RayStation, som köptes 2023.
Johan Löf, grundare och vd, RaySearch: “Vi är glada att välkomna ytterligare en ny RayCare-kund. För vår installerade bas av RayStation-kunder kommer valet av RayCare som onkologiinformationssystem att öka effektiviteten och förbättra användarupplevelsen både i dosplaneringsprocessen och vid leverans av behandlingen.”
Intäkter från ordern förväntas redovisas under 2025.
About Connecticut Proton Therapy Center
The Connecticut Proton Therapy Center will be the first center in the state of Connecticut to treat cancer patients with proton therapy. The center is a collaboration between Yale New Haven Health and Hartford HealthCare with Proton International as the contracted project manager and operator for the new center. The 20,000 sq ft. Connecticut Proton Therapy Center will be located at 932 Northrop Road in Wallingford and is on track to break ground this fall and begin treating patients in 2026.
About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems.
RaySearch's software has been sold to over 1,000 clinics in 43 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003. More information is available at raysearchlabs.com.
About RayStation
RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved.
About RayCare
The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today’s oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®. The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future.
* Subject to regulatory clearance in some markets.
For more information, please contact:
Johan Löf, founder and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0) 8 510 530 00
johan.lof@raysearchlabs.com